Organic growth could return in Q3 y/y after being negative for the past seven quarters.
Redeye retains its positive view of Carasent following the Q3 report.
Redeye shares its preview of BONESUPPORT’s Q3 2025 results, due October 23.
Interim CEO Jyri Luomakoski has been appointed as new CEO of the company.
Redeye leaves a comment following Alzinova’s announcement of a SEK11m short-term loan aimed at secur...
Duell’s Q4 results were mixed, with the Nordics outperforming expectations while Central Europe fell...
Raute reports Q3 results on Oct 30. Earnings are likely to peak at least temporarily this year, but ...
Redeye provides its initial take on Vitec’s Q3 2025 report, which came in broadly below our estimate...
* Qben Infra, MCap of SEK 846m, selling 100% of Rail.
* Strong Q3: EBIT SEK 48m (vs. SEK -23m Q3'24) * We raise our EPS assumptions, but cut '25e EBIT on ...
* Q3e: some US improvement q-o-q, Germany remains negative * Estimate cuts driven by continued subdu...
Analysguiden räknar med en omsättning om 2 mdkr och ett justerad rörelseresultat om 280 mkr för Beij...
Suominen reports Q3 results on Oct 29. H1’25 saw an earnings recovery setback so that H2 must show m...
Gold prices have continued to develop favourably since our previous update in September, up some 20%...
The trade war has both directly and indirectly negatively affected Incap.
